New Weapons to Fight against Staphylococcus aureus Skin Infections

Area of Science:

• Infectious Diseases
• Materials Science
• Pharmacology

Background:

• Antibiotic-resistant strains of Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA), pose significant challenges in treating skin and soft tissue infections.
• Current MRSA treatments suffer from poor bioavailability, unfavorable metabolism, and severe side effects.
• S. aureus can evade antibiotics by residing in biofilms or within host cells, and patient-specific factors like vascular compromise can hinder drug delivery.

Purpose of the Study:

• To review promising strategies for improving antibiotic sensitivity, bioavailability, and delivery for S. aureus infections.
• To explore alternative, non-antibiotic-based therapies for managing these challenging infections.

Main Methods:

• Literature review of current and emerging therapeutic strategies.
• Analysis of approaches combining antibiotics with other agents (nanomaterials, inhibitors, oligonucleotides, enzymes).
• Evaluation of non-antibiotic therapies such as antimicrobial peptides, nanoparticles, phototherapies, and hyperthermia.

Main Results:

• Combination therapies with bactericidal nanomaterials, chemical inhibitors, antisense oligonucleotides, and lytic enzymes show potential.
• Alternative therapies including antimicrobial peptides, bioactive glass nanoparticles, nanocrystalline cellulose, phototherapies, and hyperthermia are under investigation.
• These strategies aim to overcome resistance, improve drug penetration, and enhance overall treatment efficacy.

Conclusions:

• Novel strategies are crucial to combat the rising threat of antibiotic-resistant S. aureus.
• Combining conventional antibiotics with advanced delivery systems and exploring non-antibiotic alternatives offer promising avenues for future treatments.
• Further research and development are needed to translate these experimental therapies into clinical practice.